Anti-EGFR Antibody Cetuximab Enhances the Cytolytic Activity of Natural Killer Cells toward Osteosarcoma (Q59195965)

From Wikidata
Jump to navigation Jump to search
scientific article published on 16 November 2011
edit
Language Label Description Also known as
English
Anti-EGFR Antibody Cetuximab Enhances the Cytolytic Activity of Natural Killer Cells toward Osteosarcoma
scientific article published on 16 November 2011

    Statements

    Anti-EGFR antibody cetuximab enhances the cytolytic activity of natural killer cells toward osteosarcoma (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit